Synapse Technologies
1992
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
$15.3M
LATEST DEAL AMOUNT
Description
Developer of proprietary technology to deliver therapeutic enzymes and other drugs. The company focuses on discovery, development and commercialization of transport systems for therapeutic drug delivery across the blood brain barrier and new drug targets in neurodegenerative disease.
Primary Industry
Drug Delivery
Acquirer
Primary Office
- 6660 NorthWest Marine Drive
- Vancouver, British Columbia B6T 1Z4
- Canada
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Synapse Technologies’s full profile, request a free trial.
Synapse Technologies Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 21-Mar-2002 | $15.3M | 000 | 000.00 | Completed | Clinical Trials - General |
| 1. Later Stage VC | 12-Jan-2000 | 000 | 000 | Completed | Startup |
Synapse Technologies Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| BMO Financial Group | Lender/Debt Provider | Minority | 000 0000 | 000000 0 | ||
| Business Development Bank of Canada | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| FutureFund Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| GrowthWorks | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| MDS Ventures Pacific | Minority | 000 0000 | 000000 0 |